Literature DB >> 20320024

The Study and Treatment of Cancer by Proteolytic Enzymes: Preliminary Report.

H C Connell.   

Abstract

Entities:  

Year:  1935        PMID： 20320024      PMCID： PMC1561462     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  SEROLOGICAL RELATIONS AMONG SPORE-FORMING ANAEROBIC BACTERIA.

Authors:  E McCoy; L S McClung
Journal:  Bacteriol Rev       Date:  1938-06

2.  Noninvasive imaging of infection after treatment with tumor-homing bacteria using Chemical Exchange Saturation Transfer (CEST) MRI.

Authors:  Guanshu Liu; Chetan Bettegowda; Yuan Qiao; Verena Staedtke; Kannie W Y Chan; Renyuan Bai; Yuguo Li; Gregory J Riggins; Kenneth W Kinzler; Jeff W M Bulte; Michael T McMahon; Assaf A Gilad; Bert Vogelstein; Shibin Zhou; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2013-10-07       Impact factor: 4.668

3.  Evaluation of Clostridium novyi-NT spores in dogs with naturally occurring tumors.

Authors:  Erika L Krick; Karin U Sorenmo; Shelley C Rankin; Ian Cheong; Barry Kobrin; Katherine Thornton; Kenneth W Kinzler; Bert Vogelstein; Shibin Zhou; Luis A Diaz
Journal:  Am J Vet Res       Date:  2012-01       Impact factor: 1.156

4.  Tumor-targeting bacterial therapy: A potential treatment for oral cancer (Review).

Authors:  Sai Liu; Xiaoping Xu; Xin Zeng; Longjiang Li; Qianming Chen; Jing Li
Journal:  Oncol Lett       Date:  2014-09-11       Impact factor: 2.967

Review 5.  Microorganisms in the Treatment of Cancer: Advantages and Limitations.

Authors:  Klaudia Łukasiewicz; Marek Fol
Journal:  J Immunol Res       Date:  2018-02-27       Impact factor: 4.818

Review 6.  Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy.

Authors:  Kajal H Gupta; Christina Nowicki; Eileena F Giurini; Amanda L Marzo; Andrew Zloza
Journal:  Vaccines (Basel)       Date:  2021-12-18

7.  Tumor Temporal Proteome Profiling Reveals the Immunological Triple Offensive Induced by Synthetic Anti-Cancer Salmonella.

Authors:  Shuxin Yang; Wenjuan Zhao; Muchun Zhu; Huijuan Hu; Weijie Wang; Zhongsheng Zang; Meiling Jin; Jiacheng Bi; Jiandong Huang; Chenli Liu; Xuefei Li; Peng Yin; Nan Li
Journal:  Front Immunol       Date:  2021-08-19       Impact factor: 7.561

Review 8.  Advancing Clostridia to Clinical Trial: Past Lessons and Recent Progress.

Authors:  Alexandra M Mowday; Christopher P Guise; David F Ackerley; Nigel P Minton; Philippe Lambin; Ludwig J Dubois; Jan Theys; Jeff B Smaill; Adam V Patterson
Journal:  Cancers (Basel)       Date:  2016-06-28       Impact factor: 6.639

Review 9.  Clostridium novyi-NT in cancer therapy.

Authors:  Verena Staedtke; Nicholas J Roberts; Ren-Yuan Bai; Shibin Zhou
Journal:  Genes Dis       Date:  2016-02-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.